Does DIAZEPAM Cause Product packaging quantity issue? 5 Reports in FDA Database
Sharpen Your Memory & Focus Naturally
NeuroZoom — 35 clinically studied ingredients. No stimulants. Pure brain support.
According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Product packaging quantity issue have been filed in association with DIAZEPAM (Diazepam). This represents 0.0% of all adverse event reports for DIAZEPAM.
5
Reports of Product packaging quantity issue with DIAZEPAM
0.0%
of all DIAZEPAM reports
0
Deaths
0
Hospitalizations
How Dangerous Is Product packaging quantity issue From DIAZEPAM?
Of the 5 reports.
Is Product packaging quantity issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for DIAZEPAM. However, 5 reports have been filed with the FAERS database.
What Other Side Effects Does DIAZEPAM Cause?
Toxicity to various agents (7,262)
Drug abuse (5,609)
Somnolence (2,547)
Drug ineffective (2,500)
Completed suicide (2,359)
Intentional overdose (2,260)
Coma (2,250)
Overdose (2,134)
Suicide attempt (1,797)
Death (1,779)
What Other Drugs Cause Product packaging quantity issue?
LEUPROLIDE (523)
ALBUTEROL (431)
BUDESONIDE\FORMOTEROL (301)
FENTANYL (286)
BUPRENORPHINE (225)
CYCLOSPORINE (206)
ESTRADIOL (201)
BIMATOPROST (177)
RIVAROXABAN (174)
EXENATIDE (154)
Which DIAZEPAM Alternatives Have Lower Product packaging quantity issue Risk?
DIAZEPAM vs DIAZOXIDE
DIAZEPAM vs DICHLORPHENAMIDE
DIAZEPAM vs DICLOFENAC
DIAZEPAM vs DICLOFENAC DIETHYLAMINE
DIAZEPAM vs DICLOFENAC EPOLAMINE